Clinical Trial Update: Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin

View source ↗

Summary

A completed clinical trial comparing linezolid versus vancomycin for MRSA hospital-acquired pneumonia, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hospital-acquired Pneumonia
• Methicillin-resistant Staphylococcus Aureus Infection

Drugs mentioned

• Vancomycin (vancomycin)
• ZYVOX (LINEZOLID)

Snippet

Sponsor: Pfizer | Conditions: Methicillin-Resistant Staphylococcus Aureus (MRSA), Hospital-Acquired Pneumonia | Status: COMPLETED | Results posted: 2014-07-10